• Nenhum resultado encontrado

Rev. Bras. Hematol. Hemoter. vol.36 número6

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Hematol. Hemoter. vol.36 número6"

Copied!
2
0
0

Texto

(1)

rev bras hematol hemoter. 2014;36(6):392–393

Revista

Brasileira

de

Hematologia

e

Hemoterapia

Brazilian

Journal

of

Hematology

and

Hemotherapy

w w w . r b h h . o r g

Scientific

comment

Comment

on

“Nutritional

status

of

patients

submitted

to

transplantation

of

allogeneic

hematopoietic

stem

cells:

a

retrospective

study”

Erin

M.

Schmidt,

Kerry

K.

McMillen

SeattleCancerCareAlliance,Seattle,UnitedStates

a

r

t

i

c

l

e

i

n

f

o

Articlehistory:

Availableonline1October2014

Adultpatientsundergoinghematopoieticcelltransplantation (HCT)varywidelyintermsoftheirrequirementfornutrition interventionandassessmentofnutrientneeds.Multiple fac-torsthroughouttheHCTprocessimpactnutritionalstatusand theneedfornutritioninterventionsuchastypeof condition-ingregimen,degreeofregimen-relatedtoxicity,infectionand graft-versus-hostdisease(GVHD).

Asdemonstrated in thestudy by Ferreiraet al. entitled “Nutritionalstatusofpatientssubmittedtotransplantation ofallogeneichematopoieticstemcells:aretrospectivestudy”, nutritionstatusisadverselyaffectedearlypost-HCTby high-dose conditioning regimens requiring hospitalization and parenteralnutrition(PN)support.1However,regardlessofthe

patient’searlypost-HCTtoxicities,theirnutritionstatuscan also bedrastically affected by later complications such as acute/chronicGVHDand/orcytomegalovirus(CMV)enteritis. Long-termcomplicationsresultingfromimmunosuppressive medicationssuchassteroid-induceddiabetesmellitus, osteo-porosis, hyperlipidemia and metabolic syndrome can also affectnutritionstatusformonthstoyearsafterHCT.

DOIoforiginalarticle:http://dx.doi.org/10.1016/j.bjhh.2014.06.001. 夽

SeepaperbyFerreiraetal.onpages420–3.

Correspondingauthorat:SeattleCancerCareAlliance,Seattle,WA,UnitedStates. E-mailaddress:[email protected](K.K.McMillen).

Werecommendaninitialnutritionassessmentbya reg-istered dietitianforall patientsundergoing allogeneic HCT due totheanticipated nutritionissues associatedwiththe conditioning regimen. Ideally, the initial nutrition assess-ment occurs prior to starting the conditioning regimen and includes anthropometrics, laboratory data, diet com-position/preferences, oral/gastrointestinal symptoms and comorbidities.Ifapatientisidentifiedashighnutritionrisk pre-HCT, intensivedietcounselingand/ornutritionsupport mayberecommendedinthepre-HCTtimeframeinorderto maximizenutritionstatusattimeofhospitaladmission. Addi-tionally,serialnutritionassessmentisnecessarytoaddress post-HCTcomplicationsthatalternutrientintake,absorption, andutilization.2

Parenteral nutrition is not uniformly indicated for all patients with less use among reduced-intensity and non-myeloablativepatients.3–7LengthoftimeonPNinthisstudy

may beinfluencedbythefactthatthe majorityofpatients receivedbonemarrowinfusionvs.peripheralbloodstemcell infusionwhich isassociatedwithshorterengraftment and

http://dx.doi.org/10.1016/j.bjhh.2014.09.008

(2)

revbrashematolhemoter.2014;36(6):392–393

393

decreaseddaysofparenteralnutritionsupport.8Close

moni-toringbyanutritionsupportteam,includingadietitian,helps preventoverfeedingand minimizes hyperglycemia particu-larlywhileapatientmaystillbemeetingapercentageoftheir calorieneedsorally.Thedietitiancanalsodetermine appro-priatetimingtodiscontinuePNtherebyminimizinglengthof daysonnutritionsupportandcost.9Asregimen-related

toxi-citiesresolve,itisimportanttostresstolerablefoodssuchas lowfiber,andsoftorpureedfoodstoincreasecalorie-protein intakeandallowsafediscontinuationofPN.PNcanbesafely discontinuedoncepatientsmeet30%ofestimatedneeds with-outsignsofmalabsorption.10,11

Controversy exists regarding “neutropenic diet pre-cautions”. Many hospitals continue to restrict fresh fruits/vegetables, yogurts, spices and herbs despite the factthatstudieshaveshownthatstrict“neutropenic diets” donotdecrease infection rates.2,12,13 Greater availability of

these foods may, in fact, improve flavor, palatability and tolerance as oral and gastrointestinal symptoms resolve allowingexpeditedcalorie-proteinintake.

WithlateronsetGVHD,whetheracuteorchronic,nutrition counselingisimportanttohelppatientsmakefoodchoicesfor besttoleranceandsymptommanagementwhilestillmeeting calorie-proteingoalstopreserveleanbodymass.Oftendiet and/ortexturemodificationarerequiredfororaland gastroin-testinalGVHD.Insomecases,particularlywithchronicGVHD, enteral nutrition may be the best option to meet calorie-proteingoalswheneverfeasible.Enteralnutritionismorecost effectiveandmaintainsmucosalintegritywithlowerriskof infection.14,15

Weagree that nutritionstatus is compromised in allo-geneicHCTpatientsduringtheirhospitalstay.However,for allallogeneicHCT patients,itisimportanttoconsiderthat theirlifelongnutritionstatusmaycontinuetobeinfluenced bysequelaeresultingfromHCT.

Conflicts

of

interest

Theauthorsdeclarenoconflictsofinterest.

r

e

f

e

r

e

n

c

e

s

1. FerreiraEE,GuerraDC,BaluzK,FurtadoWR,BouzasLF.

Nutritionalstatusofpatientssubmittedtotransplantationof

allogeneichematopoieticstemcells:aretrospectivestudy.

RevBrasHematolHemoter.2014;36(6):420–3.

2. AugustDA,HuhmannMB,AmericanSocietyforParenteral

andEnteralNutrition(A.S.P.E.N.)BoardofDirectors.A.S.P.E.N.

clinicalguidelines:nutritionsupporttherapyduringadult

anticancertreatmentandinhematopoieticcell

transplantation.JPENJParenterEnteralNutr.

2009;33(5):472–500.

3.IestraJA,FibbeWE,ZwindermanAH,RomijnJA,KromhoutD.

Parenteralnutritionfollowingintensivecytotoxictherapy:an

exploratorystudyontheneedforparenteralnutritionafter

varioustreatmentapproachesforhaematological

malignancies.BoneMarrowTransplant.1999;23(9):933–9.

4.DiaconescuR,FlowersCR,StorerB,SorrorML,MarisMB,

MaloneyDG,etal.Morbidityandmortalitywith

nonmyeloablativecomparedwithmyeloablativeconditioning

beforehematopoieticcelltransplantationfromHLA-matched

relateddonors.Blood.2004;104(5):1550–8.

5.TopcuogluP,AratM,OzcanM,ArslanO,IlhanO,BeksacM,

etal.Case-matchedcomparisonwithstandardversus

reducedintensityconditioningregimeninchronicmyeloid

leukemiapatients.AnnHematol.2012;91(4):577–86.

6.ParkerJE,ShafiT,PagliucaA,MijovicA,DevereuxS,PotterM,

etal.Allogeneicstemcelltransplantationinthe

myelodysplasticsyndromes:interimresultsofoutcome

followingreduced-intensityconditioningcomparedwith

standardpreparativeregimens.BrJHaematol.

2002;119(1):144–54.

7.MielcarekM,MartinPJ,LeisenringW,FlowersME,Maloney

DG,SandmaierBM,etal.Graft-versus-hostdiseaseafter

nonmyeloablativeversusconventionalhematopoieticstem

celltransplantation.Blood.2003;102(2):756–62.

8.HoltickU,AlbrechtM,ChemnitzJM,TheurichS,SkoetzN,

ScheidC,etal.Bonemarrowversusperipheralblood

allogeneichaematopoieticstemcelltransplantationfor

haematologicalmalignanciesinadults.CochraneDatabase

SystRev.2014;20(4).CD010189.

9.HagiwaraS,MoriT,TuchiyaH,SatoS,HigaM,WatahikiM,

etal.Multidisciplinarynutritionalsupportforautologous

hematopoieticstemcelltransplantation:acost–benefit

analysis.Nutrition.2011;27(11/12):1112–7.

10.SternJM,BruemmerB,MoinpourCM,SullivanKM,LenssenP,

AkerSN.Impactofarandomized,controlledtrialofliberalvs

conservativehospitaldischargeonenergy,protein,andfluid

intakeinpatientswhoreceivedmarrowtransplants.JAm

DietAssoc.2000;100(9):1015–22.

11.CharuhasPM,FosbergKL,BruemmerB,AkerSN,Leisenring

W,SeidelK,etal.Adouble-blindrandomizedtrialcomparing

outpatientparenteralnutritionwithintravenoushydration:

effectonresumptionoforalintakeaftermarrow

transplantation.JPENJParenterEnteralNutr.

1997;21(3):157–61.

12.DeMilleD,DemingP,LupinacciP,JacobsLA.Theeffectofthe

neutropenicdietintheoutpatientsetting:apilotstudy.Oncol

NursForum.2006;33(2):337–43.

13.MoodyK,FinlayJ,MancusoC,CharlsonM.Feasibilityand

safetyofapilotrandomizedtrialofinfectionrate:

neutropenicdietversusstandardfoodsafetyguidelines.J

PediatrHematolOncol.2006;28(3):126–33.

14.LipkinA,LenssenP,DicksonBJ.Nutritionissuesin

hematopoieticstemcelltransplantation:stateoftheart.Nutr

ClinPract.2005;20(4):423–39.

15.ThompsonJL,DuffyJ.Nutritionsupportchallengesin

hematopoieticstemcelltransplantpatients.NutrClinPract.

Referências

Documentos relacionados

ingly, an additional consequence of IB disruption in patients with hematological malignancies is a higher risk of acute graft-versus-host disease (aGVHD) in patients submitted

Nevertheless, the alterations contained in the new regulations (ANVISA Resolution RDC 57/2010 and MoH Ordinance 2712/2013) were minimal with regard to screening donors for malaria

In this case, despite the medical staff having asserted that the patient was not undergoing curative therapy, the parents denied the unfavorable progression of the disease and did

The aim of the study was to evaluate the intestinal barrier function in leukemic patients prior to chemotherapy, by test- ing intestinal permeability by the determination of

Our results suggest that patients submitted to allogeneic HSCT have a worsening in their nutritional status during hospital- ization, mainly characterized by weight loss,

Objective: The purpose of this study was to evaluate the effectiveness of mature red cell and reticulocyte parameters under three conditions: iron deficiency anemia, anemia of

Mutations that reflect defects in the Klotho gene expression may be implicated in the onset of osteonecrosis, pri- apism, and leg ulcers in patients with sickle cell disease, as

Two deaths (28.6%) occurred in patients with suspected primary hemophagocytic lymphohistiocytosis; one whose clinical picture was triggered by cytomegalovirus infection did not